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Abstract
1,3-butadiene (BD) is an important industrial chemical and a common environmental pollutant
present in urban air. BD is classified as a human carcinogen based on epidemiological evidence
for an increased incidence of leukemia in workers occupationally exposed to BD and its potent
carcinogenicity in laboratory mice. A diepoxide metabolite of BD, 1,2,3,4-diepoxybutane (DEB),
is considered the ultimate carcinogenic species of BD due to its ability to form genotoxic DNA-
DNA cross-links. We have previously employed capillary HPLC-ESI+-MS/MS methods to
quantify DEB-induced DNA-DNA conjugates, e.g. 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-
BD), 1-(guan-7-yl)-4-(aden-1-yl)-2,3-butanediol (N7G-N1A-BD), and 1,N6-(1-hydroxymethyl-2-
hydroxypropan-1,3-diyl)-2′-deoxyadenosine (1,N6-HMHP-dA), in tissues of laboratory mice
exposed to 6.25 – 625 ppm BD (Goggin et al. Cancer Research 69(6), 2479–2486, 2009).
However, typical BD human exposure levels are 0.01 to 3.2 ppb in urban air and 1– 2.0 ppm in an
occupational setting, requiring greater detection sensitivity for these critical lesions. In the present
study, a nanoHPLC-nanoESI+-MS/MS method was developed for ultra-sensitive, accurate, and
precise quantitation of bis-N7G-BD in tissues of laboratory mice treated with low ppm and sub-
ppm concentrations of BD. The LOD value of the new method is 0.5 fmol/100 μg DNA, and the
LOQ is 1.0 fmol/100 μg DNA, making it possible to quantify bis-N7G-BD adducts present at
concentrations of 3 per 109 nucleotides. Bis-N7G-BD adduct amounts in liver tissues of mice
exposed to 0.5, 1.0, 1.5 ppm BD for 2 weeks were 5.7 ± 3.3, 9.2 ± 1.5, and 18.6 ± 6.9 adducts per
109 nucleotides, respectively, suggesting that N7G-BD adduct formation is more efficient under
low exposure conditions. To our knowledge, this is the first quantitative analysis of DEB specific
DNA adducts following low ppm and sub-ppm exposure to BD.
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1,3-Butadiene (BD) is an important industrial chemical commonly used in rubber and plastic
manufacturing1 and an environmental pollutant present in automobile exhaust2 and in
cigarette smoke.3 BD is classified as human carcinogen based on epidemiological studies in
occupationally exposed workers that revealed an increased incidence of leukemia and
lymphohematopoietic cancers.4–7 Furthermore, inhalation experiments with laboratory
animals have shown that BD is a multi-site carcinogen, inducing lung, liver, heart stomach
and other solid tumors in mice8 and thyroid, pancreas, uterus, testes and other tissue tumors
in rats.9 BD requires metabolic activation to DNA-reactive epoxides 3,4-epoxy-1-butene
(EB), 1, 2, 3, 4-diepoxybutane (DEB), and 1,2-dihydroxy-3,4-epoxybutane (EBD).10;11
Among these, DEB is the most genotoxic, inducing base substitutions, sister chromatid
exchanges, and chromosomal aberrations in vitro and in vivo.11–13 Large interspecies
differences between mutagenicity and carcinogenicity of BD in mouse and rat animal
models8;9 have been attributed to more efficient metabolic activation of BD to DEB in the
mouse.14–16 Because of its key role in carcinogenicity of BD, there is a need for sensitive
biomarkers of DEB formation in vivo.
Georgieva et al. have developed DEB-specific biomarkers based on N-terminal valine
hemoglobin adducts (Hb) adducts, namely N,N-[2,3-dihydroxy-1,4-butyl]valine (pyr-
Val).17;18 Pyr-Val adducts have been detected in blood of B6C3F1 mice and F344 rats
exposed to BD as low as 0.5 ppm BD.18 More recently, Pyr-Val adducts were observed in
blood of occupationally exposed workers at concentrations of 0.08–0.86 pmol/g globin.19
Hb-based biomarkers are valuable because protein adducts are not repaired and therefore are
representative of cumulative exposure to DEB over time (the lifetime of red blood cells is ~
120 days in humans, 45 days in mice, and 63 days in rats). However, Hb based biomarkers
may not represent a biologically relevant dose of DEB since protein adducts do not lead to
mutations, and DNA rather than cellular proteins is the ultimate biological target of
genotoxic carcinogens such as DEB.
Our laboratory previously identified several DEB-specific DNA adducts including DNA-
DNA cross-links, 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD) and 1-(guan-7-yl)-4-
(aden-1-yl)-2,3-butanediol (N7G-N1A-BD), and an exocyclic DEB-dA adduct, 1,N6-(1-
hydroxymethyl-2-hydroxypropan-1,3-diyl)-2′-deoxyadenosine (1,N6-HMHP-dA)(Scheme
1).20–25 DEB-specific bifunctional DNA adducts have been quantified in tissues of
laboratory rats and mice that were exposed to 6.25–625 ppm of BD by inhalation.26 Among
DEB-DNA adducts, bis-N7G-BD were present at the highest concentration (3.95 ± 0.89
adducts/107 nucleotides (nts) in livers of mice exposed to 625 ppm BD), followed by N7G-
N1A-BD(0.27 ± 0.07 adducts/107 nts) and 1,N6-HMHP-dA (0.044 ± 0.008 adducts/107
nts).23;26
While our previously described capillary HPLC-ESI+-MS/MS methods were adequate for
detection of bis-N7G-BD in tissues of laboratory animals exposed to 6.25 ppm BD and
higher,26 greater sensitivity is required in order to detect DEB-DNA adducts following
typical human exposures (1 ppm and lower). In the present work, we have developed and
validated a nanoHPLC-nanoESI+-MS/MS method for quantitative analysis of bis-N7G-BD
in vivo. The sensitivity and accuracy of the new method are as follows: LOD: 0.5 fmol/100
μg DNA, LOQ: 1.0 fmol/100 μg DNA, and accuracy: 97.1 ± 6.3 % (n = 5). To our
knowledge, this is the first quantitative analysis of DEB-specific DNA adducts following
exposure to occupationally relevant BD concentrations (OSHA limit = 1 ppm).27 Our results
indicate that bis-N7G-BD formation is more efficient at low BD exposure levels (< 1.5
ppm), probably because a greater fraction of BD is metabolized to DEB. These results will
be useful for human risk assessment from exposure to BD.
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DEB is a known carcinogen and must be handled with adequate safety precautions. Phenol
and chloroform are toxic chemicals that should be handled in a well-ventilated fume hood
with appropriate personal protective equipment.
LC-MS grade water, methanol and acetonitrile were obtained from Fisher Scientific
(Pittsburgh, PA). All other chemicals and solvents were obtained from Sigma-Aldrich
(Millwaukee, WI, St. Louis, MO) with the exception of bis-N7G-BD and [15N10]-bis-N7G-
BD, which were prepared in our laboratory as described elsewhere.20;21;28
Animals and treatment
BD inhalation exposure experiments were performed at the Lovelace Respiratory Research
Institute (Albuquerque, NM) as previously reported.26 Briefly, B6C3F1 female mice (5 per
group) were exposed to 0, 0.5, 1.0, or 1.5 ppm BD by inhalation for 2 weeks (6 h/day, 5
days/week). Animals were euthanized by cardiac puncture at the end of the exposure period.
Liver tissues were collected, flash frozen, and shipped to the University of Minnesota on dry
ice, where they were stored at −80 °C.
Cell culture
V79 chinese hamster lung fibroblasts (CHL cells) were obtained from the Coriell institute
(Camden, NJ, USA). Cells were grown to confluence on 15 cm dishes in Ham’s F-12
modified essential Eagle’s media supplemented with 9% fetal bovine serum. The cell culture
was maintained in a humidified environment containing 5% carbon dioxide and 95% air at
37°C. Cells were subjected to serial passage at a dilution of 1:10 following brief exposure to
porcine pancreatic trypsin and mechanical agitation. All experiments were performed on
cells at a low passage number.
DNA isolation
DNA was isolated from mouse liver tissue using NucleoBond AXG500 anion exchange
cartridges (Macherey-Nagel) according to the manufacturer’s instructions. DNA employed
for method validation was isolated from CHL-V79 cells by standard phenol-chloroform
extraction. DNA concentrations were estimated using UV spectrophotometry. DNA purity
was assessed from A260/A280 absorbance ratio, which was typically between 1.7 and 1.8.
DNA amounts were determined by quantitation of dG in enzymatic hydrolysates as
described below.
dG quantitation
DNA aliquots (~ 10 μg) were enzymatically digested with phosphodiesterase I (6.0 mU/μg
DNA), phosphodiesterase II (8.0 mU/μg DNA), DNase (3.0 U/μg DNA), and alkaline
phosphatase (6.69 U/μg DNA) in 10 mM Tris-HCl/15 mM MgCl2 (pH 7.2) at 37 °C
overnight. HPLC-UV analysis of dG was conducted by HPLC-UV using a Zorbax SB-C8
column (4.6 × 150 mm, 5 μm, from Agilent Technologies, Palo Alto, CA) eluted with a
gradient of 150 mM ammonium acetate (A) and acetonitrile (B) as described previously.29
Neutral thermal hydrolysis and isolation of bis-N7G-BD adducts
DNA samples (100 μg) were spiked with 50 fmol of S,S;R,R 15N10- bis-N7G-BD
(racemic 15N10- bis-N7G-BD, internal standard for mass spectrometry) and incubated at 70
°C for 1 hour to release bis-N7G-BD from the DNA backbone as a free base conjugate.
Partially depurinated DNA was removed by ultrafiltration with Nanosep 10K filters (Pall
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Life Sciences, Ann Arbor, MI). The filtrates containing bis-N7G-BD and its internal
standard were purified by offline HPLC. A Zorbax Eclipse XDB-C18 (4.6 × 150 mm, 5 μm,
from Agilent Technologies, Palo Alto, CA) column was eluted at 1 mL/min with a gradient
of 0.4% formic acid in Milli-Q water (A) and HPLC grade acetonitrile (B). Solvent
composition was maintained at 0% B for 5 min and then increased to 3% B in 10 min and
further to 40% B in 5 min. The solvent composition was returned to 0% B in 5 min and
maintained at 0% B for 15 min. 2′-deoxythymidine (dT) and 2′-deoxyadenosine (dA) (12.0
nmol each) were added as retention time markers, eluting at 13.7 and 18.8 min, respectively.
HPLC fractions containing bis-N7G-BD and its internal standard (14 – 18 min, about 1.25
mL) were collected, concentrated under vacuum, and dissolved in water (25 μL) for
nanoHPLC-nanoESI+-MS/MS analysis.
nanoLC-nanoESI+-MS/MS analysis of bis-N7G-BD
A Waters nanoAcquity UPLC system (Waters Corp., Millford, MA) interfaced to a Thermo-
Finnigan TSQ Quantum UltraAM mass spectrometer (Thermo Fisher Scientific Corp.,
Waltham, MA) was used in all analyses. HPLC solvents were 0.01% acetic acid in LC-MS
grade water (A) and LC-MS grade methanol: acetonitrile (1:1) (B). Samples (8 μL) were
loaded on a trapping column (Symmetry C18 nanoAcquity, 0.18 × 20 mm, Waters Corp.,
Millford, MA) for 1 min at 0% B at a flow rate of 10 μL/min. Chromatographic separation
was achieved with a nano-HPLC column (75μm × 200 mm) manually packed with Zorbax
SB-C18, 5 μm chromatographic packing (Agilent Tech. Santa Clara, CA). The column was
eluted at a flow rate of 0.4 μL/min. Solvent composition was maintained at 0% B for 1 min,
then linearly increased to 10% B in 2 min, further to 50% B in 8 min, and finally to 80% B
in 5 min. Solvent composition returned to 0 %B for a 14 min equilibration at a flow rate of
0.4 μL/min. Under these conditions, bis-N7G-BD eluted as a sharp peak at ~15 min.
The triple quadrupole mass spectrometer was fitted with a nanospray source from Thermo
Fisher Scientific Corp. (Waltham, MA). The instrument was operated in the positive ion ESI
mode with Ar as a collision gas (1.4 mTorr). The mass spectrometer was tuned upon
infusion of authentic bis-N7G-BD solution to achieve maximum sensitivity. Quantitative
analyses were conducted in the selected reaction monitoring (SRM) mode by following the
MS/MS transitions corresponding to the neutral loss of guanine from protonated molecules
of the analyte (m/z 389.1 [M + H]+ → m/z 238.1 [M + H − Gua]+), and the formation of
protonated guanine (m/z 389.1 [M + H]+ → m/z 152.1 [Gua + H]+). Typical instrument
settings included a spray voltage of 2.0 kV, capillary temperature at 300 °C, and the
collision energy at 32 and 22 V for the first and the second SRM transition, respectively.
The corresponding transitions for the 15N10-isotopically-labeled internal standard were m/z
399.1 [15N10-M + H]+ → m/z 243.1 [M + H − [15N5]Gua]+ and m/z 157.1 [15N5-Gua + H]+.
The Q1 peak width was 0.4 amu, while the peak width for Q2 was 0.7 amu. The scan width
was 0.4 amu, and the scan time was 0.5 s. NanoHPLC-nanoESI+-MS/MS quantitation was
based on the areas of the peaks in the extracted ion chromatograms corresponding to the
analyte and the internal standard.
Method standard curves were constructed by analyzing solutions containing a fixed amount
of 15N10-bis-N7G-BD (50 fmol) and increasing amounts of bis-N7G-BD (0.5, 1.0, 5.0, 10.0,
15.0, 25.0, and 50.0 fmol) in water (in triplicate), followed by regression analysis of the
actual and the observed amounts of bis-N7G-BD (Figure S-1 in the Supporting Information).
Solvent blanks were periodically injected to monitor for potential analyte carry-over.
Method validation
DNA isolated from CHL V-79 cells (100 μg, in triplicate) was spiked with 0, 1, 5, 10, 15, 25
or 50 fmol of bis-N7G-BD and 50 fmol 15N10-bis-N7G-BD internal standard. Following
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heating at 70 °C for 1 hour (neutral thermal hydrolysis), samples were filtered through
Nanosep-10K ultra- centrifugation devices. Bis-N7G-BD and its internal standard were
purified by off-line HPLC as described above and subjected to nanoHPLC-nanoESI+-MS/
MS analysis by usual methods. Regression analysis was conducted to compare the measured
and the spiked amounts of bis-N7G-BD.
Determination of LOD/LOQ, precision, and accuracy
DNA extracted from CHL V-79 cells (100 μg) was spiked with 1, 0.75, 0.5, or 0.1 fmol of
bis-N7G-BD and 50.0 fmol of 15N10-bis-N7G-BD. Samples were subjected to thermal
hydrolysis and ultrafiltration, purified by offline HPLC, and analyzed by nanoHPLC-
nanoESI+-MS/MS as described above. Method limit of quantification (LOQ) was estimated
as the amount of analyte which gave a signal-to-noise ratio (S/N) greater than 10 at % CV <
15%. Method limit of detection (LOD) was determined as the amount of analyte that
produced a signal-to-noise ratio > 3.
To evaluate the interday and intraday accuracy and precision of the new method, bis-N7G-
BD (2.0 fmol) and 15N10-bis-N7G-BD (50.0 fmol) were spiked into blank DNA isolated
from CHL V-79 cells (100 μg). Samples were processed as described above and analyzed
three times per day on three consecutive days. Method accuracy was calculated from the
equation (Am/Aa × 100%), where Am is the measured amount of bis-N7G-BD and Aa is the
actual amount added.
Analysis of bis-N7G-BD in mouse liver samples—DNA was extracted from livers of
B6C3F1 mice exposed to 0, 0.5, 1.0 or 1.5 ppm BD by inhalation (2 weeks at 6 h/day, 5
days/week) using the methodology described above. Each exposure group contained five
animals. DNA aliquots (100 μg in 200 μL water) were subjected to neutral thermal
hydrolysis (70 °C for 1 hr), followed by Nanosep10K ultra filtration and offline HPLC as
described above. Our previous experiments have confirmed that these conditions efficiently
release bis-N7G-BD adducts form the DNA backbone. 21;28 Bis-N7G-BD adducts were
quantified using the newly validated nanoHPLC-nanoESI+-MS/MS method. Adduct
numbers were expressed as adduct numbers per 107 nucleotides. DNA amounts were
determined by HPLC-UV analysis of dG in DNA hydrolysates as described above.
Method reproducibility—DNA was extracted from six 100 mg aliquots of liver from
F344 rat treated with 62.5 ppm BD by inhalation and analyzed by the standard methodology.
An additional two aliquots were extracted by the Quagen DNA extraction kit and analyzed




The goal of the present study was to develop ultra-sensitive methodologies to quantify bis-
N7G-BD adducts in tissues of mice exposed to low ppm and sub- ppm levels of BD. In our
approach (Scheme 2), genomic DNA is spiked with [15N10]-bis-N7G-BD internal standard,
and bis-N7G-BD lesions are released from the DNA backbone by neutral thermal
hydrolysis. Our previous results indicate that heating at 70 °C for 1 h results in a quantitative
release of bis-N7G-BD cross-links.21;26 Following the removal of partially depurinated
DNA via ultrafiltration, bis-N7G-BD and its internal standard are isolated from the bulk of
the sample matrix using off-line HPLC. HPLC fractions containing the analyte and its
internal standard are then dried, reconstituted in buffer, and subjected to nanoHPLC-
nanoESI+-MS/MS analysis with a triple quadrupole mass spectrometer. Our new method
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employs a flow rate of 0.4 μL/min and nanoESI MS/MS detection as compared to the earlier
capillary HPLC-ESI-MS/MS method that uses a flow rate of 10 μL/min.26
nanoHPLC-nanoESI+-MS/MS method development and validation—MS/MS
fragmentation pattern of bis-N7G-BD in a triple quadrupole mass spectrometer is
characterized by predominant product ion peaks at m/z 238.1 corresponding to neutral loss
of guanine base from protonated molecules of the adduct [M + H − Gua]+.21 Another
abundant fragment at m/z 152.1 corresponds to protonated guanine ions [Gua + H]+ (Figure
1). The corresponding fragments for the corresponding 15N10 isotopically labeled internal
standard are m/z 243.1 [M + H − [15N5]Gua]+ and m/z 157.1 [15N5-Gua + H]+.
Our quantitative method for bis-N7G-BD is based on selected reaction monitoring of the
MS/MS transitions m/z 389.1 [M + H]+ → m/z 238.1 [M + H − Gua]+ and m/z 389.1 [M +
H]+ → m/z 152.1 [Gua + H]+. The corresponding transitions for the 15N10-isotopically-
labeled internal standard are m/z 399.1 [15N10-M + H]+ → m/z 243.1 [M + H − [15N5]Gua]+
and m/z 157.1 [15N5-Gua + H]. A sum of the two transitions is used for quantitation to
improve sensitivity.
To optimize analyte separation from interfering components of the biological matrix, the
new method employs an offline HPLC sample cleanup. dT and dA are spiked in each
sample as retention time markers, eluting at 13.7 and 18.8 min, respectively, while the
retention time of bis-N7G-BD and its internal standard is ~16 min. HPLC fractions
containing bis-N7G-BD and 15N10-bis-N7G-BD (14 – 18 min, about 1.25 mL) were
collected and concentrated for nanoLC-nanoESI+-MS/MS analysis.
We have chosen nanospray LC-MS method over conventional capillary flow LC-MS
because of its greater sensitivity. When HPLC flow rate is reduced to < 1 μL/min, droplet
formation in the electrospray source occurs more readily, requiring only the applied voltage
(typically 2000V) and no nebulizing gas to generate a spray.30 The efficiency of
electrospray ionization is greatly improved under nanoflow conditions, because a smaller
amount of mobile phase passes through the emitter, producing fine aerosol droplets.
Consequently, the stability of ion spray, and therefore MS signal, is improved, thus leading
to improved detection sensitivity.31;32 As an additional benefit, nanoHPLC methods
consume very small amounts of solvents as compared to conventional capillary flow LC MS
methods. Several laboratories, including ours, have previously reported the use of nanospray
for sensitive quantitation of DNA adducts.33–37
Several HPLC stationary phases were evaluated during the nanoHPLC method development,
including Symmetry C18 (Waters Corp., Millford, MA), Luna C18 (Phenomenex, Torrance,
CA), HILIC-NH2 (Phenomenex, Torrance, CA), Synergi Polar RP and Hydro RP
(Phenomenex, Torrance, CA). The best analyte retention and peak shape were obtained with
Zorbax SB-C18 stationary phase (Agilent Technologies, Santa Clara, CA). We found that
the best sensitivity was achieved with a gradient of 0.01% aqueous acetic acid (solvent A)
and acetonitrile: methanol (1:1, solvent B). All solvents were LC-MS grade. Using a linear
gradient between 10% and 100% B, bis-N7G-BD adducts eluted at 14.5 min and were
resolved from any impurities present in DNA hydrolysates (Figure 2).
Method Validation—The limit of detection of the nanoHPLC-nanoESI+-MS/MS method
was estimated as 50 amol bis-N7G-BD on column, a significant increase in sensitivity as
compared to our previous capillary HPLC-ESI+-MS/MS method.26 To validate the new
methodology, blank DNA isolated from Chinese hamster lung fibroblasts (100 μg) was
spiked with known amounts of bis-N7G-BD and corresponding 15N10-labelled internal
standard, followed by sample processing and nanoHPLC-nanoESI+-MS/MS analysis as
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described above. An excellent correlation was observed between the expected and observed
concentrations of bis-N7G-BD, with an R2 value of 0.999 (Figure 3). We found that the
method’s lower limit of quantitation (S/N ratio of 10 or better) was 1.0 fmol bis-N7G-BD in
0.1 mg DNA (3 bis-N7G-BD adducts per 109 nts), and the LOD value was 0.5 fmol/0.1 mg
DNA. The LOD value for pure standard of bis-N7G-BD was 0.1 fmol (Figure S-2). Method
accuracy (n = 5) and precision (n = 3) were determined for replicates of bis-N7G-BD (2.0
fmol) spiked into 0.1 mg of DNA. Method accuracy was determined to be 97.1 ± 6.3 % (n =
5) and the interday and intraday precision were less than 8 % RSD (n = 3) (Table 1).
Analysis of bis-N7G-BD in mouse liver DNA—The newly validated quantitative
nanoHPLC-nanoESI+-MS/MS method was employed to analyze the formation of bis-N7G-
BD adducts in liver DNA of B6C3F1 mice that were exposed to 0.5 – 1.5 ppm BD by
inhalation for 2 weeks. Representative extracted ion chromatogram from nanoHPLC-
nanoESI+-MS/MS analysis of bis-N7G-BD in liver DNA samples from a mouse exposed to
1.0 ppm BD is shown in Figure 2. We found that DNA extracted from tissues of mice
treated with 0.5 ppm BD for 2 weeks contained 5.7 ± 3.3 bis-N7G-BD adducts per 109
normal nucleotides (N = 4), while animals exposed to 1.0 ppm BD contained 9.2 ± 1.5 bis-
N7G-BD adducts per 109 nts (N = 5) and those exposed to 1.5 ppm BD contained 18.6 ± 6.9
bis-N7G-BD adducts per 109 normal nucleotides (N = 5). DNA of control animals (N = 5)
did not contain detectable amounts of bis-N7G-BD (Figure 4).
Discussion
A potent human and animal carcinogen, BD is metabolically activated to DEB, which reacts
with DNA to form DNA-DNA cross links, e.g. 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-
BD).20–23 If not repaired, the interstrand bis-N7G-BD adducts can block DNA replication
and transcription and lead to genotoxicity, while the corresponding intrastrand lesions are
likely to be mutagenic.28 It is important to determine the molecular dose of DEB following
BD exposure because of its central role in BD-mediated adverse health effects. In particular,
DEB is 100–200-fold more mutagenic than other epoxide metabolites of BD,11 and is
thought to be responsible for most of the genotoxic effects of BD at low exposure
concentrations (< 62.5 ppm BD).12
bis-N7G-BD lesions have been previously identified and quantified in laboratory animals
exposed to relatively high concentrations of BD 6.25–625 ppm.26 However, DEB-specific
DNA adducts have not been previously analyzed in animals subjected to BD exposures
approaching the human Occupational Safety and Health Administration (OSHA) time
weighted average levels (1 ppm).27 Ambient BD concentrations in monomer and polymer
work places range from 0.3 to 3 ppm. New and improved bioanalytical methods were
required in order to quantify bis-N7G-BD adducts in tissues following low ppm and sub-
ppm exposures.
In the present study, an ultra sensitive nanoHPLC-nanoESI+-MS/MS was developed for
quantitation of bis-N7G-BD in liver DNA of mice exposed to sub-ppm levels of BD.
Capillary flow HPLC-ESI-MS based methods typically employed for DNA adduct analysis
are limited in their sensitivity due to the presence of relatively large amounts of solvent,
which reduces the efficiency of ion formation in the ESI source. In contrast, nanospray
analysis is characterized by more efficient ionization and improved sensitivity.30;38
Therefore, we have adopted a nanospray LC-MS/MS methodology for quantitative analysis
bis-N7G- BD in vivo. Our new analytical method is more sensitive than our previous
capillary HPLC-ESI-MS/MS methodology (LOQ, 1.0 fmol) because of an improved sample
clean up by offline HPLC and the inherent advantages of nanospray HPLC-ESI-MS/MS.
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NanoHPLC-nanospray MS/MS methodology has been recently employed for the detection
of 7-ethylguanine adducts in leukocyte DNA isolated from smokers and non smokers.36
Solid phase extraction was employed for sample cleanup following DNA hydrolysis, and
MS analyses were conducted with an Orbitrap LTQ Velos mass spectrometer using an
accurate mass mode.36 The LOD and LOQ values of the method were reported as 0.1 fmol
on column and 8 fmol per 180 μg DNA, respectively.36 Zarbl et al. employed nanoHPLC-
nanospray MS to detect and quantitate DNA adducts in bronchial epithelial cells treated with
10−5 – 10−8 M concentrations of the N-hydroxy- 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP), a potent food carcinogen present in overcooked meat.37
In another recent study, Chen et al. employed nanoHPLC-nanospray MS/MS technique to
analyze 1,N2-propano-2′-deoxy-guanosine adducts derived from acrolein (AdG) and
crotonaldehyde (CdG) in various human DNA samples from saliva, human placenta and
blood leukocytes.33–35 Three lipid peroxidation-related etheno adducts:1,N6-etheno-2′-
deoxyadenosine (εdAdo), 3,N4-etheno-2′-deoxycytidine (εdCyt), and 1,N2-etheno-2′-
deoxyguanosine (1,N2- εdGuo) were also analyzed by nanoHPLC-nanospray MS/MS.34 The
limits of quantification per 5 μg of DNA were reported as 0.31 fmol, 1.5 fmol, 0.36 fmol,
2.0 fmol, and 1.7 fmol for AdG and CdG, εdAdo, εdCyd, and 1,N2- εdGuo, respectively.33
Our nanoHPLC-nanospray MS/MS methodology for bis-N7G-BD in tissue DNA described
herein is comparable to previously reported nanoHPLC-nanospray MS/MS methods in
sensitivity (LOD: 0.5 fmol and LOQ: 1.0 fmol in 100μg DNA), accuracy, and precision
(Table 1). With this methodology, it is possible to detect 3 bis-N7G-BD adducts per 109
nucleotides. Since DNA-DNA cross-links are less abundant in DNA than DNA
monoadducts such as 7-ethylguanine, an offline HPLC sample cleanup was required to
provide a higher degree of separation than can be afforded by solid phase extraction. While
such a cleanup step increases the overall analysis time, minimal operator involvement is
required with the use of an automated HPLC system incorporating an HPLC autosampler
and a fraction collector.
Using the validated nanoHPLC-nanospray MS/MS method, bis-N7G-BD adduct amounts
were determined in livers of B6C3F1 mice following a 2 week exposure to 0.5, 1.0, or 1.5
ppm BD (6 h/day, 5 days/week, see Figure 4). No bis-N7G-BD was detected in liver DNA
of control mice (N = 5) which have not been exposed to BD. A comparison of the numbers
of bis-N7G-BD adducts/107 nucleotides/ppm of BD under low ppm exposure conditions
determined in the present study to our earlier data for animals exposed to higher BD
concentrations (6.25–625 ppm)26 shows that there is higher ratio of bis-N7G-BD adduct
numbers per ppm of BD at low levels of BD exposure as compared to BD exposures greater
than 62.5 ppm (Figure 5). Table 2 provides a comparison of bis-N7G-BD adduct levels per
unit dose of BD to pyr-Val adducts (picomoles per gram of globin) per ppm of BD exposure
in female mice. Taken together, our results indicate that bis-N7G-BD adduct formation is
more efficient at low concentrations of BD (≤ 6.25 ppm) as compared to higher exposure
concentrations (≥ 62.5 ppm), probably a result an increased bioactivation of BD to DEB
under low exposure conditions. These results are relevant because typical occupational or
environmental exposure of humans to BD is 2 ppm or less.
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Refer to Web version on PubMed Central for supplementary material.
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NanoLC-nanoESI+-MS/MS analysis of a mixture of pure bis-N7G-BD (1.0 fmol)
and 15N10-bis-N7G-BD (10 fmol).
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NanoHPLC-nanoESI+-MS/MS analysis of bis-N7G-BD in a sample of liver DNA from a
mouse exposed to 1.0 ppm BD for 2 weeks.
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NanoHPLC-nanoESI+-MS/MS method validation curve for bis-N7G-BD spiked into blank
DNA (0.1 mg).
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Concentrations of bis-N7G-BD adducts in liver tissues of B6C3F1 female mice (4–5 per
group) exposed to 0, 0.5, 1.0, or 1.5 ppm BD by inhalation for 2 weeks (6 h/day, 5 days/
week).
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Dose-dependent formation of bis-N7G-BD in liver DNA of female B6C3F1mice exposed to
BD for 2 weeks by inhalation (6 h/day, 5 days/week). The 6.25 and 62.5 ppm values were
taken from our earlier publication.26
Sangaraju et al. Page 15














Metabolism of 1,3-butadiene to DEB and its reactions with DNA to form bis-N7G-BD
adducts.
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Table 1
Accuracy and precision of nanoHPLC-nanoESI+-MS/MS analysis for bis-N7G-BD (2 fmol) spiked into blank
DNA (0.1 mg).
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Table 2
Efficiency of formation of bis-N7G-BD adducts in mouse liver DNA (DNA adducts per exposure level) and
pyr-Val adducts (hemoglobin adducts per exposure level) in mice exposed from sub-ppm to high levels of BD
for 2 weeks (6 h/day, 5 days/week).












From our previous study.26
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